Metabolomics Workbench : NIH Data Repository

Reversed phase NEGATIVE ION MODE (Analysis AN003429)

Metabolite	Structure	F1	F2	F3	F4	F5	F6
P-Coumaric acid	ME510810	0.37	2.24	0.90	1.52	0.49	0.48
Deoxycholic acid	ME510815	0.39	0.28	1.90	1.80	1.09	0.54
Taurochenodeoxycholic acid	ME510809	0.19	0.54	0.83	0.87	1.93	1.63
Taurodeoxycholic acid	ME510811	0.19	0.53	0.84	0.87	1.94	1.63
Indoxyl sulfate	ME510821	1.40	0.81	1.09	0.79	1.12	0.79
Azelaic acid	ME510818	1.34	0.92	1.00	1.17	0.89	0.69
Malonic acid	ME510817	1.19	0.75	1.07	1.35	0.84	0.80
L-Lactate	ME510812	0.87	0.95	0.94	0.82	1.21	1.21
Oxalic acid	ME510816	0.87	0.96	0.94	0.84	1.17	1.23
Malic acid	ME510822	0.73	1.25	0.79	0.94	1.05	1.25
D-Fructose	ME510823	0.62	1.26	1.13	0.99	0.87	1.13
Glucose	ME510825	0.67	1.10	1.05	0.99	1.04	1.14
Pyruvate	ME510813	0.98	0.97	1.27	1.00	0.91	0.88
Succinic acid	ME510824	0.93	1.26	1.14	0.91	0.89	0.88
N-Acetyl-L-tryptophan	ME510819	0.76	1.34	1.04	0.78	1.29	0.78
Phenyllactic acid	ME510829	0.93	1.32	0.97	1.05	1.07	0.67
2-Ketoglutaric acid	ME510814	0.44	1.67	0.96	1.10	0.85	0.97
Citrate	ME510807	0.76	1.29	0.87	1.39	0.94	0.75
Isocitric acid	ME510808	0.74	1.26	0.81	1.62	0.87	0.70
Allantoin	ME510820	0.57	1.28	0.59	0.74	1.44	1.39
Docosahexaenoic acid	ME510828	1.23	0.61	0.80	0.58	1.54	1.23
2-hydroxy-2-phenylpropanoic acid	ME510826	1.13	0.62	0.76	0.63	1.50	1.37
3-Hydroxyphenylpropionic acid	ME510827	1.11	0.62	0.77	0.63	1.51	1.36

F1	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)
F2	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)
F3	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)
F4	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)
F5	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.
F6	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.

Data matrix